Publications of Lutz W. Kracht
All genres
Journal Article (57)
21.
Journal Article
37 (1), pp. 84 - 92 (2010)
Volumetry of [11C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme. European Journal of Nuclear Medicine and Molecular Imaging 22.
Journal Article
133 (7), pp. 1994 - 2006 (2010)
Spreading depolarizations cycle around and enlarge focal ischaemic brain lesions. Brain 23.
Journal Article
50 (12), pp. 1962 - 1968 (2009)
Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. Journal of Nuclear Medicine 24.
Journal Article
93 (3), pp. 425 - 430 (2009)
Imaging biological activity of a glioblastoma treated with an individual patient-tailored, experimental therapy regimen. Journal of Neuro-Oncology 25.
Journal Article
36 (12), pp. 1960 - 1967 (2009)
Non-invasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high grade glioma. European Journal of Nuclear Medicine and Molecular Imaging 26.
Journal Article
33 (12), pp. 922 - 924 (2008)
Perrault Syndrome with progressive nervous system involvement. Clinical Nuclear Medicine 27.
Journal Article
71 (10), pp. 708 - 713 (2008)
STN-DBS activates the target area in Parkinson disease. An FDG-PET study. Neurology 28.
Journal Article
47 (2), pp. 73 - 79 (2008)
Multi-modality imaging of uveal melanomas using combined PET/CT, high-resolution PET and MR imaging. Nuklearmedizin-Nuclear Medicine 29.
Journal Article
44 (1), pp. 29 - 45 (2008)
Functional retrograde amnesia: a multiple case study. Cortex 30.
Journal Article
65 (3), pp. 407 - 411 (2008)
Altered cerebral glucose metabolism in a family with clinical features resembling mitochondrial neurogastrointestinal encephalomyopathy syndrome in association with multiple mitochondrial DNA deletions. Archives of Neurology 31.
Journal Article
14 (7), pp. 2049 - 2055 (2008)
Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Clinical Cancer Research 32.
Journal Article
28 (4), pp. 484 - 494 (2008)
Neuroimaging in patients with gliomas. Seminars in Neurology 33.
Journal Article
51 (2), pp. 164 - 181 (2007)
Role of in vivo imaging of the central nervous system for developing novel drugs. Quarterly Journal of Nuclear Medicine and Molecular Imaging 34.
Journal Article
51 (2), pp. 164 - 181 (2007)
Developing novel drugs by in vivo imaging of the CNS. Quarterly Journal of Nuclear Medicine and Molecular Imaging 35.
Journal Article
33 (5), pp. 516 - 524 (2006)
Use of C-11-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. European Journal of Nuclear Medicine and Molecular Imaging 36.
Journal Article
26 (9), pp. 1122 - 1127 (2006)
Direct demonstration of transcallosal disinhibition in language networks. Journal of Cerebral Blood Flow and Metabolism 37.
Journal Article
46 (12), pp. 1948 - 1958 (2005)
F-18-fluoro-L-thymidine and C-11-methylmethionine as markers of increased transport and proliferation in brain tumors. Journal of Nuclear Medicine 38.
Journal Article
139 (2), pp. 115 - 126 (2005)
Reduced glucose metabolism in temporo-parietal cortices of women with borderline personality disorder. Psychiatry Research-Neuroimaging 39.
Journal Article
36 (2), p. 440 - 440 (2005)
Severity of ischemia determines space-occupying brain edema after middle cerebral artery infarction. Stroke 40.
Journal Article
2 (2), pp. 333 - 347 (2005)
Imaging in neurooncology. NeuroRx